InflaRx stock trades at 1.12 euros on November 10

Company: InflaRx N.V.
ISIN: NL0012661870
Ticker: IFRX
Trading venue: Lang & Schwarz
Quote: 1.12 euros at 13:31 CET on Tuesday, November 10, 2026
Bid / ask: 1.10 / 1.15 euros

Published on 11/10/2026 at 13:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

InflaRx stock was quoted during Tuesday's European session. Investors can also track the company's latest capital-markets announcements and development milestones.

Key points for investors

InflaRx's investor-relations page lists a September 21, 2026 release on a virtual Capital Markets Day.
The 2026 press-release calendar includes updates on izicopan and other development milestones.

IFRX, NL0012661870, Illustration mit AI erstellt.

InflaRx stock traded at 1.12 euros on Lang & Schwarz at 13:31 CET on Tuesday, November 10, 2026. The quote came with a 1.10-euro bid and a 1.15-euro ask.

Corporate calendar remains relevant

InflaRx's investor-relations page lists a September 21, 2026 release titled InflaRx to Host Virtual Capital Markets Day. The company also lists 2026 updates covering izicopan, clinical development and corporate milestones.

For investors, the latest Lang & Schwarz quote offers an intraday reference while the company's development calendar remains a central part of the equity story. The bid-ask spread indicates the range between current buying and selling interest at the time of the quote.